4MOODLEY J,MOODLEY D,PILLAY K,et al. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidowdine in human immunodeficiency virus type Ⅰ-infected pregnant women and their offspring[J]. J Infect Dis, 1998,178: 1327-1333.
5MANDELBORT L,PEYTAVIN G,FIRTION G,et al. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women [J]. Am J Obstet Gynecol,2001,184:153- 158.
6POIRIER MC,OLIVERO OA,WALKER DM,et al. Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs[J]. Toxicol Appl Pharmacol,2004. 199: 151-161.
9[4]Lai C1,Liaw YF,Leung NWY,et al,Genotypic resistance to lamivudine in aprospective,placebo-controlledmulticentral study in Asia of lamiudine therapy for chronic hepatitis B infection,Incidence,kinetics of emergency,and correlation with diseaseparameters.Hepatol-ogy,1997,26:259A
4Shao ZJ, Zhang L, Xu JQ, et al. Mother- to- infant transmission of hepatitis B virus: a Chinese experi- ence[J]. J Med Virol,2011,83(5) :791 - 795.
5Chen HL, Lin LH, Hu FC,et al. Effects of maternal screening and universal immunization to prevent mother- to- infant transmission of HBV[J]. Gas- troenterology, 2012,142 (4) : 773 - 781.
6Zou H, Chen Y, Duan Z, et al. Protective effect of hepatitis B vaccine combined with two- dose hepati- tis B immunoglo- bulin on infants born to HBsAg - positive mothers [J]. PloS One, 2011, 6 (10) : e26748.
7Hoofnagle JH, doo E, Liang TJ, et al. Management of hepatitis B: summary of a clinical research workshop [J]. Hepatology,2007,45(4) : 1056 - 1075.
8Qiu SX,Wu SM,Jiang PR, et al. The relationship of serum hepatitis B virus DNA load in HBsAg positive pregnant women to the intrauterine infection of new- borns[J]. Shanghai J Prev Med, 2005, 17 (9) : 428 - 429.
